ChinaBIO 2022, Cromos Pharma, digital CRO conference

Connect with Cromos Pharma at ChinaBIO 2022

Cromos Pharma’s Chief Business Development Officer, Yuri Shchagin, and BD Director APAC&Western Europe, Serhii Yeletskyi, are delighted to be taking part in the virtual  ChinaBIO 2022. The event is scheduled to take place November 10-11.

The virtual part of the conference presents two days of networking, programming, and partnering possibilities. The goal of the conference is to engage with the largest network of potential partners to accelerate the cross-border strategies and expand the reach into the China market.

Our team is pleased to be taking part in this event. It’s always a great opportunity to hear from leaders in global pharma and biotech and to meet with potential partners. We look forward to sharing with you some of the benefits Cromos Pharma can bring to your next project including our No Patients – No Payment risk-sharing initiative.

Yuri and Serhii would love to learn about your clinical development plans and discuss ways in which Cromos Pharma can provide support. If you are searching for a partner for clinical trials in Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye, they will be happy to present you with details and insights into these markets. Our solutions help accelerate the drug development process, making it more efficient and effective.

About Cromos Pharma

Cromos Pharma is a US-based, international contract research organization delivering fully integrated clinical research solutions, in all trial phases, across a wide range of therapeutic indications. Our expert team, comprised of 95% MDs, has extensive expertise in study design, medical writing, regulatory affairs, site management, patient recruitment and data management.

Cromos Pharma has experience in delivering success in a wide range of trial types, from biosimilars and generics, to successfully managing trials of novel therapeutics in a wide range of clinical indications. Our team provides full-service solutions to international pharma and biotech companies in high-recruiting regions, assuring exceptional data quality. Cromos Pharma combines global expertise with in-depth experience and knowledge in the US, Central and Eastern Europe, Central Asia, Republic of Georgia, and Türkiye resulting in rapid patient recruitment. Our team has met or reduced enrollment timelines in 95% of conducted trials.

We provide accelerated study start-up timelines in our regions of operation. Regulatory inspections by FDA and EMA and site audits attest to the highest quality of our clinical data.

Established in 2004, Cromos Pharma has strong regional experience that is supported by a global network of offices. Its international HQ is in Portland, Oregon, USA and its European HQ is in Dublin, Ireland.

If you have any questions or want to find out more about how Cromos Pharma can support your next clinical program, please get in touch with us by emailing



To arrange an introductory meeting and find out how our experience can benefit your next clinical project.